Hormone replacement therapy is legal in Florida for adults, but the rules split sharply depending on why it’s prescribed. Standard HRT for menopause, hormone deficiency, or similar medical conditions follows the same prescribing rules as any other medication. Gender-affirming hormone therapy is legal for adults 18 and older under tighter restrictions enacted in 2023, and it is banned for minors with only narrow exceptions.
Standard and Menopausal HRT
If you need hormone therapy for menopausal symptoms, osteoporosis prevention, or a diagnosed hormone deficiency, Florida treats it like any other prescription. A physician licensed under Chapter 458 (MD) or Chapter 459 (DO) can prescribe it, and so can advanced practice registered nurses and physician assistants working within their scope of practice. No special consent form or in-person ceremony applies beyond the standard informed consent required for any medical treatment.
Under Florida’s Medical Consent Law, your provider must give you enough information about the treatment’s nature, risks, benefits, and alternatives that a reasonable person would understand what they are agreeing to.1The Florida Legislature. Florida Code 766.103 – Florida Medical Consent Law In practice that means a conversation with your doctor and a standard consent form. The FDA updated labeling on several menopausal hormone therapy products in February 2026, removing certain boxed warnings related to cardiovascular disease and breast cancer risk, which may change how your provider frames the risk discussion.2U.S. Food and Drug Administration. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
Gender-Affirming HRT for Adults
Gender-affirming hormone therapy is legal for adults in Florida, but Florida Statute 456.52, created by Senate Bill 254 in 2023, adds requirements that don’t apply to other forms of HRT.
Only a Physician Can Prescribe
Only an MD licensed under Chapter 458 or a DO licensed under Chapter 459 can prescribe gender-affirming hormones. Nurse practitioners, physician assistants, and other mid-level providers are excluded, even when they would normally be authorized to prescribe those same medications for other purposes.3Florida Senate. Florida Code 456.52 – Sex-Reassignment Prescriptions and Procedures; Prohibitions; Informed Consent A testosterone prescription for a man with low testosterone can come from a PA. The same prescription written for a transgender man cannot.
In-Person Informed Consent
The consent process is stricter than standard informed consent. The prescribing physician must be physically present in the same room with you, not on a video call, and must use a consent form specifically adopted by the Board of Medicine or Board of Osteopathic Medicine. You sign the form acknowledging you have been informed of the nature and risks of the treatment before any prescription is written.3Florida Senate. Florida Code 456.52 – Sex-Reassignment Prescriptions and Procedures; Prohibitions; Informed Consent
Telehealth Limits
Federal telehealth flexibilities extended by HHS and the DEA through December 31, 2026 allow many controlled substances to be prescribed without a prior in-person visit,4HHS.gov. HHS and DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026 but Florida’s statute overrides that convenience for gender-affirming care. The initial consent must happen in person. After that first visit, ongoing care with the same physician may continue virtually. Switching providers means a new in-person consent with the new physician.
Insurance and Public Funding
SB 254 prohibits public entities from spending state funds on gender-affirming prescriptions and procedures,5Florida Senate. CS/SB 254 – Treatments for Sex Reassignment which means Florida Medicaid does not cover gender-affirming hormone therapy. Private insurance may cover it depending on the plan, so verify before you start. Menopausal HRT and hormone therapy for other medical conditions are not affected by this restriction and remain eligible for standard coverage, including Medicaid where medically necessary.
Gender-Affirming HRT for Minors
Florida bans gender-affirming hormone therapy and puberty blockers for anyone under 18. Section 456.52 prohibits prescribing or administering hormones intended to align a minor’s physical characteristics with a gender identity that differs from their biological sex.3Florida Senate. Florida Code 456.52 – Sex-Reassignment Prescriptions and Procedures; Prohibitions; Informed Consent
The exceptions are narrow. A minor born with a medically verifiable genetic disorder of sexual development may receive treatment. Minors already receiving gender-affirming hormones before May 17, 2023 (when SB 254 took effect) could continue under emergency rules adopted by the Board of Medicine, which required parental informed consent and concurrent counseling from a board-certified psychiatrist or licensed psychologist.3Florida Senate. Florida Code 456.52 – Sex-Reassignment Prescriptions and Procedures; Prohibitions; Informed Consent No new patients under 18 can start gender-affirming hormones in Florida.
Penalties for Providers Who Violate the Law
Any health care practitioner who willfully participates in prescribing or administering prohibited gender-affirming treatment to a patient under 18 commits a third-degree felony,6Florida Senate. Florida Senate – CS for SB 254 which carries up to five years in prison under Florida’s sentencing framework. The Florida Department of Health can immediately suspend the license of any practitioner arrested for violating the minor prohibition. The medical boards also retain their standard disciplinary authority, including license revocation, suspension, probation, fines, and required continuing education.7Florida Senate. Florida Code 766.102 – Medical Negligence; Standards of Recovery; Expert Witness
Where the Law Stands After Skrmetti
Florida’s restrictions were challenged in federal court in Doe v. Ladapo. A federal district judge permanently blocked enforcement of the SB 254 provisions on minors and some adult restrictions in June 2024. In August 2024 a three-judge panel of the Eleventh Circuit stayed that injunction, allowing Florida to enforce the law while the appeal continued.8United States Court of Appeals for the Eleventh Circuit. Order of the Court in Doe v. Ladapo
In June 2025 the U.S. Supreme Court decided United States v. Skrmetti, a challenge to Tennessee’s nearly identical ban. In a 6-3 decision, the Court held that such bans satisfy rational basis review and do not violate the Equal Protection Clause, reasoning that classifying treatments by diagnosis rather than by a patient’s sex or transgender status is constitutionally permissible and that states have a legitimate interest in protecting minors from treatments the legislature found carry risks including irreversible effects.9Supreme Court of the United States. United States v. Skrmetti, 605 U.S. ___ (2025) The ruling strengthens Florida’s position in the pending Eleventh Circuit case and makes a successful federal constitutional challenge to the minor ban unlikely under current law.
Practical Takeaways
Menopausal or standard medical HRT: any qualified prescriber, standard consent, standard insurance rules.
Gender-affirming HRT as an adult: confirm your prescriber is an MD or DO, plan for an in-person visit before your first prescription, sign the state-approved consent form, and check whether your private insurance covers the medication, since Medicaid will not.
Gender-affirming HRT for a minor: new prescriptions are not available in Florida outside the narrow disorder-of-sexual-development exception and the pre-May 2023 continuation pathway.